Global Standard Peptide Custom Synthesis Service Supply, Demand and Key Producers, 2024-2030

Publication ID:

GIR032400336

Publication Date:

March 1, 2024

Pages:

134

Publisher:

GIR

Countries:

Global [1]

USD 4,480.00

Software [2]

IT Services [3]

Computing & Electronics [4]

Description:

The global Standard Peptide Custom Synthesis Service market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Standard Peptide Custom Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Standard Peptide Custom Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Standard Peptide Custom Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Standard Peptide Custom Synthesis Service total market, 2019-2030, (USD Million)
Global Standard Peptide Custom Synthesis Service total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Standard Peptide Custom Synthesis Service total market, key domestic companies and share, (USD Million)
Global Standard Peptide Custom Synthesis Service revenue by player and market share 2019-2024, (USD Million)
Global Standard Peptide Custom Synthesis Service total market by Type, CAGR, 2019-2030, (USD Million)
Global Standard Peptide Custom Synthesis Service total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Standard Peptide Custom Synthesis Service market based on the following parameters 鈥� company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm and Genscript, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Standard Peptide Custom Synthesis Service market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Standard Peptide Custom Synthesis Service 麻豆原创, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Standard Peptide Custom Synthesis Service 麻豆原创, Segmentation by Type
CRO Peptides
CMO Peptides
Generic API Peptides
Global Standard Peptide Custom Synthesis Service 麻豆原创, Segmentation by Application
Commercial
Academic Research
Companies Profiled:
Bachem
PolyPeptide
GL Biochem
Xinbang
Hybio
USVPeptides
Thermofischer
ScinoPharm
Genscript
AnaSpec
New England Peptide
CPC Scientific
JPT
21st Century Bio
LifeTein
Proimmune
Biomatik
Key Questions Answered
1. How big is the global Standard Peptide Custom Synthesis Service market?
2. What is the demand of the global Standard Peptide Custom Synthesis Service market?
3. What is the year over year growth of the global Standard Peptide Custom Synthesis Service market?
4. What is the total value of the global Standard Peptide Custom Synthesis Service market?
5. Who are the major players in the global Standard Peptide Custom Synthesis Service market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Supply Summary
1.1 Standard Peptide Custom Synthesis Service Introduction
1.2 World Standard Peptide Custom Synthesis Service 麻豆原创 Size & Forecast (2019 & 2023 & 2030)
1.3 World Standard Peptide Custom Synthesis Service Total 麻豆原创 by Region (by Headquarter Location)
1.3.1 World Standard Peptide Custom Synthesis Service 麻豆原创 Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Standard Peptide Custom Synthesis Service 麻豆原创 Size (2019-2030)
1.3.3 China Standard Peptide Custom Synthesis Service 麻豆原创 Size (2019-2030)
1.3.4 Europe Standard Peptide Custom Synthesis Service 麻豆原创 Size (2019-2030)
1.3.5 Japan Standard Peptide Custom Synthesis Service 麻豆原创 Size (2019-2030)
1.3.6 South Korea Standard Peptide Custom Synthesis Service 麻豆原创 Size (2019-2030)
1.3.7 ASEAN Standard Peptide Custom Synthesis Service 麻豆原创 Size (2019-2030)
1.3.8 India Standard Peptide Custom Synthesis Service 麻豆原创 Size (2019-2030)
1.4 麻豆原创 Drivers, Restraints and Trends
1.4.1 Standard Peptide Custom Synthesis Service 麻豆原创 Drivers
1.4.2 Factors Affecting Demand
1.4.3 Standard Peptide Custom Synthesis Service Major 麻豆原创 Trends
2 Demand Summary
2.1 World Standard Peptide Custom Synthesis Service Consumption Value (2019-2030)
2.2 World Standard Peptide Custom Synthesis Service Consumption Value by Region
2.2.1 World Standard Peptide Custom Synthesis Service Consumption Value by Region (2019-2024)
2.2.2 World Standard Peptide Custom Synthesis Service Consumption Value Forecast by Region (2025-2030)
2.3 United States Standard Peptide Custom Synthesis Service Consumption Value (2019-2030)
2.4 China Standard Peptide Custom Synthesis Service Consumption Value (2019-2030)
2.5 Europe Standard Peptide Custom Synthesis Service Consumption Value (2019-2030)
2.6 Japan Standard Peptide Custom Synthesis Service Consumption Value (2019-2030)
2.7 South Korea Standard Peptide Custom Synthesis Service Consumption Value (2019-2030)
2.8 ASEAN Standard Peptide Custom Synthesis Service Consumption Value (2019-2030)
2.9 India Standard Peptide Custom Synthesis Service Consumption Value (2019-2030)
3 World Standard Peptide Custom Synthesis Service Companies Competitive Analysis
3.1 World Standard Peptide Custom Synthesis Service Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Standard Peptide Custom Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Standard Peptide Custom Synthesis Service in 2023
3.2.3 Global Concentration Ratios (CR8) for Standard Peptide Custom Synthesis Service in 2023
3.3 Standard Peptide Custom Synthesis Service Company Evaluation Quadrant
3.4 Standard Peptide Custom Synthesis Service 麻豆原创: Overall Company Footprint Analysis
3.4.1 Standard Peptide Custom Synthesis Service 麻豆原创: Region Footprint
3.4.2 Standard Peptide Custom Synthesis Service 麻豆原创: Company Product Type Footprint
3.4.3 Standard Peptide Custom Synthesis Service 麻豆原创: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of 麻豆原创 Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Standard Peptide Custom Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Standard Peptide Custom Synthesis Service 麻豆原创 Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Standard Peptide Custom Synthesis Service Revenue 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Standard Peptide Custom Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: Standard Peptide Custom Synthesis Service Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Standard Peptide Custom Synthesis Service Consumption Value 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Standard Peptide Custom Synthesis Service Companies and 麻豆原创 Share, 2019-2024
4.3.1 United States Based Standard Peptide Custom Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Standard Peptide Custom Synthesis Service Revenue, (2019-2024)
4.4 China Based Companies Standard Peptide Custom Synthesis Service Revenue and 麻豆原创 Share, 2019-2024
4.4.1 China Based Standard Peptide Custom Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Standard Peptide Custom Synthesis Service Revenue, (2019-2024)
4.5 Rest of World Based Standard Peptide Custom Synthesis Service Companies and 麻豆原创 Share, 2019-2024
4.5.1 Rest of World Based Standard Peptide Custom Synthesis Service Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Standard Peptide Custom Synthesis Service Revenue, (2019-2024)
5 麻豆原创 Analysis by Type
5.1 World Standard Peptide Custom Synthesis Service 麻豆原创 Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 CRO Peptides
5.2.2 CMO Peptides
5.2.3 Generic API Peptides
5.3 麻豆原创 Segment by Type
5.3.1 World Standard Peptide Custom Synthesis Service 麻豆原创 Size by Type (2019-2024)
5.3.2 World Standard Peptide Custom Synthesis Service 麻豆原创 Size by Type (2025-2030)
5.3.3 World Standard Peptide Custom Synthesis Service 麻豆原创 Size 麻豆原创 Share by Type (2019-2030)
6 麻豆原创 Analysis by Application
6.1 World Standard Peptide Custom Synthesis Service 麻豆原创 Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Commercial
6.2.2 Academic Research
6.3 麻豆原创 Segment by Application
6.3.1 World Standard Peptide Custom Synthesis Service 麻豆原创 Size by Application (2019-2024)
6.3.2 World Standard Peptide Custom Synthesis Service 麻豆原创 Size by Application (2025-2030)
6.3.3 World Standard Peptide Custom Synthesis Service 麻豆原创 Size by Application (2019-2030)
7 Company Profiles
7.1 Bachem
7.1.1 Bachem Details
7.1.2 Bachem Major Business
7.1.3 Bachem Standard Peptide Custom Synthesis Service Product and Services
7.1.4 Bachem Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.1.5 Bachem Recent Developments/Updates
7.1.6 Bachem Competitive Strengths & Weaknesses
7.2 PolyPeptide
7.2.1 PolyPeptide Details
7.2.2 PolyPeptide Major Business
7.2.3 PolyPeptide Standard Peptide Custom Synthesis Service Product and Services
7.2.4 PolyPeptide Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.2.5 PolyPeptide Recent Developments/Updates
7.2.6 PolyPeptide Competitive Strengths & Weaknesses
7.3 GL Biochem
7.3.1 GL Biochem Details
7.3.2 GL Biochem Major Business
7.3.3 GL Biochem Standard Peptide Custom Synthesis Service Product and Services
7.3.4 GL Biochem Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.3.5 GL Biochem Recent Developments/Updates
7.3.6 GL Biochem Competitive Strengths & Weaknesses
7.4 Xinbang
7.4.1 Xinbang Details
7.4.2 Xinbang Major Business
7.4.3 Xinbang Standard Peptide Custom Synthesis Service Product and Services
7.4.4 Xinbang Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.4.5 Xinbang Recent Developments/Updates
7.4.6 Xinbang Competitive Strengths & Weaknesses
7.5 Hybio
7.5.1 Hybio Details
7.5.2 Hybio Major Business
7.5.3 Hybio Standard Peptide Custom Synthesis Service Product and Services
7.5.4 Hybio Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.5.5 Hybio Recent Developments/Updates
7.5.6 Hybio Competitive Strengths & Weaknesses
7.6 USVPeptides
7.6.1 USVPeptides Details
7.6.2 USVPeptides Major Business
7.6.3 USVPeptides Standard Peptide Custom Synthesis Service Product and Services
7.6.4 USVPeptides Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.6.5 USVPeptides Recent Developments/Updates
7.6.6 USVPeptides Competitive Strengths & Weaknesses
7.7 Thermofischer
7.7.1 Thermofischer Details
7.7.2 Thermofischer Major Business
7.7.3 Thermofischer Standard Peptide Custom Synthesis Service Product and Services
7.7.4 Thermofischer Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.7.5 Thermofischer Recent Developments/Updates
7.7.6 Thermofischer Competitive Strengths & Weaknesses
7.8 ScinoPharm
7.8.1 ScinoPharm Details
7.8.2 ScinoPharm Major Business
7.8.3 ScinoPharm Standard Peptide Custom Synthesis Service Product and Services
7.8.4 ScinoPharm Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.8.5 ScinoPharm Recent Developments/Updates
7.8.6 ScinoPharm Competitive Strengths & Weaknesses
7.9 Genscript
7.9.1 Genscript Details
7.9.2 Genscript Major Business
7.9.3 Genscript Standard Peptide Custom Synthesis Service Product and Services
7.9.4 Genscript Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.9.5 Genscript Recent Developments/Updates
7.9.6 Genscript Competitive Strengths & Weaknesses
7.10 AnaSpec
7.10.1 AnaSpec Details
7.10.2 AnaSpec Major Business
7.10.3 AnaSpec Standard Peptide Custom Synthesis Service Product and Services
7.10.4 AnaSpec Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.10.5 AnaSpec Recent Developments/Updates
7.10.6 AnaSpec Competitive Strengths & Weaknesses
7.11 New England Peptide
7.11.1 New England Peptide Details
7.11.2 New England Peptide Major Business
7.11.3 New England Peptide Standard Peptide Custom Synthesis Service Product and Services
7.11.4 New England Peptide Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.11.5 New England Peptide Recent Developments/Updates
7.11.6 New England Peptide Competitive Strengths & Weaknesses
7.12 CPC Scientific
7.12.1 CPC Scientific Details
7.12.2 CPC Scientific Major Business
7.12.3 CPC Scientific Standard Peptide Custom Synthesis Service Product and Services
7.12.4 CPC Scientific Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.12.5 CPC Scientific Recent Developments/Updates
7.12.6 CPC Scientific Competitive Strengths & Weaknesses
7.13 JPT
7.13.1 JPT Details
7.13.2 JPT Major Business
7.13.3 JPT Standard Peptide Custom Synthesis Service Product and Services
7.13.4 JPT Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.13.5 JPT Recent Developments/Updates
7.13.6 JPT Competitive Strengths & Weaknesses
7.14 21st Century Bio
7.14.1 21st Century Bio Details
7.14.2 21st Century Bio Major Business
7.14.3 21st Century Bio Standard Peptide Custom Synthesis Service Product and Services
7.14.4 21st Century Bio Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.14.5 21st Century Bio Recent Developments/Updates
7.14.6 21st Century Bio Competitive Strengths & Weaknesses
7.15 LifeTein
7.15.1 LifeTein Details
7.15.2 LifeTein Major Business
7.15.3 LifeTein Standard Peptide Custom Synthesis Service Product and Services
7.15.4 LifeTein Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.15.5 LifeTein Recent Developments/Updates
7.15.6 LifeTein Competitive Strengths & Weaknesses
7.16 Proimmune
7.16.1 Proimmune Details
7.16.2 Proimmune Major Business
7.16.3 Proimmune Standard Peptide Custom Synthesis Service Product and Services
7.16.4 Proimmune Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.16.5 Proimmune Recent Developments/Updates
7.16.6 Proimmune Competitive Strengths & Weaknesses
7.17 Biomatik
7.17.1 Biomatik Details
7.17.2 Biomatik Major Business
7.17.3 Biomatik Standard Peptide Custom Synthesis Service Product and Services
7.17.4 Biomatik Standard Peptide Custom Synthesis Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.17.5 Biomatik Recent Developments/Updates
7.17.6 Biomatik Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Standard Peptide Custom Synthesis Service Industry Chain
8.2 Standard Peptide Custom Synthesis Service Upstream Analysis
8.3 Standard Peptide Custom Synthesis Service Midstream Analysis
8.4 Standard Peptide Custom Synthesis Service Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned:

Bachem
PolyPeptide
GL Biochem
Xinbang
Hybio
USVPeptides
Thermofischer
ScinoPharm
Genscript
AnaSpec
New England Peptide
CPC Scientific
JPT
21st Century Bio
LifeTein
Proimmune
Biomatik

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.